HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hedy Teppler Selected Research

Ertapenem (Invanz)

8/2005Acquisition of resistant bowel flora during a double-blind randomized clinical trial of ertapenem versus piperacillin-tazobactam therapy for intraabdominal infections.
6/2004Treatment of polymicrobial infections: post hoc analysis of three trials comparing ertapenem and piperacillin-tazobactam.
6/2004Safety and tolerability of ertapenem.
7/2003[New Beta-lactam agent in the treatment of intra-abdominal sepsis: double blind and randomized stage III study of ertapenem versus piperacillin/tazobactam].
5/2003Efficacy of ertapenem in the treatment of serious infections caused by Enterobacteriaceae: analysis of pooled clinical trial data.
2/2003Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial.
1/2003Ertapenem once a day versus piperacillin-tazobactam every 6 hours for treatment of acute pelvic infections: a prospective, multicenter, randomized, double-blind study.
11/2002Comparative in vitro activities of ertapenem against bacterial pathogens from patients with acute pelvic infection.
9/2002Ertapenem monotherapy versus combination therapy with ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections in adults.
1/2002Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hedy Teppler Research Topics

Disease

24Infections
01/2021 - 01/2002
6HIV Infections (HIV Infection)
01/2020 - 05/2004
5Exanthema (Rash)
01/2021 - 01/2011
5Intraabdominal Infections
08/2005 - 09/2002
5Pelvic Infection
06/2004 - 01/2002
4Nausea
11/2017 - 06/2004
3Headache (Headaches)
11/2017 - 11/2009
3Coinfection
11/2017 - 06/2004
2Tuberculosis (Tuberculoses)
03/2021 - 11/2019
2Hepatitis B
01/2018 - 11/2017
2Dizziness (Lightheadedness)
11/2017 - 11/2009
2Immune Reconstitution Inflammatory Syndrome
12/2015 - 01/2011
2Acquired Immunodeficiency Syndrome (AIDS)
11/2014 - 05/2002
2Neoplasms (Cancer)
01/2011 - 07/2008
2Mycoses (Diseases, Fungus)
01/2006 - 09/2004
2Neutropenia
01/2006 - 09/2004
1Sleep Initiation and Maintenance Disorders (Insomnia)
02/2014
1Psychomotor Agitation (Akathisia)
02/2014
1Hepatitis
01/2011
1Invasive Candidiasis
01/2006
1Aspergillosis
01/2006
1Fever (Fevers)
09/2004
1Invasive Fungal Infections
09/2004
1Fatigue
05/2004
1Sepsis (Septicemia)
07/2003
1Urinary Tract Infections (Urinary Tract Infection)
05/2003
1Pneumonia (Pneumonitis)
05/2003
1Aphthous Stomatitis (Aphthous Ulcer)
05/2002
1Wasting Syndrome (Wasting Disease)
05/2002

Drug/Important Bio-Agent (IBA)

20Raltegravir PotassiumFDA Link
03/2021 - 10/2007
11Ertapenem (Invanz)FDA Link
08/2005 - 01/2002
10Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric
08/2005 - 01/2002
9Pharmaceutical PreparationsIBA
11/2019 - 06/2004
4Tenofovir (Viread)FDA Link
01/2021 - 01/2017
4Emtricitabine (Emtriva)FDA Link
01/2021 - 01/2017
4efavirenz (Sustiva)FDA Link
01/2021 - 11/2009
4Ceftriaxone (Ceftriaxon)FDA LinkGeneric
06/2004 - 09/2002
3RNA (Ribonucleic Acid)IBA
12/2018 - 11/2017
3NucleosidesIBA
01/2015 - 05/2004
2Rifampin (Rifampicin)FDA LinkGeneric
03/2021 - 11/2019
2doravirineIBA
01/2021 - 01/2019
2Human immunodeficiency virus 1 p31 integrase proteinIBA
01/2020 - 10/2007
2LopinavirFDA Link
01/2015 - 01/2015
2Ritonavir (Norvir)FDA Link
01/2015 - 01/2015
2Transaminases (Aminotransferases)IBA
02/2014 - 01/2011
2Caspofungin (Cancidas)FDA Link
01/2006 - 09/2004
2beta-LactamsIBA
07/2003 - 02/2003
2Anti-Bacterial Agents (Antibiotics)IBA
07/2003 - 02/2003
2Metronidazole (Metric)FDA LinkGeneric
11/2002 - 09/2002
1RacivirIBA
01/2021
1LipidsIBA
01/2021
1Lamivudine (Epivir)FDA Link
01/2021
1Integrase InhibitorsIBA
12/2018
1IntegrasesIBA
03/2011
1Indicators and Reagents (Reagents)IBA
01/2006
1liposomal amphotericin BFDA Link
09/2004
1Alanine Transaminase (SGPT)IBA
06/2004
1Interleukin-2 (IL2)IBA
05/2004
1Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)FDA Link
11/2002
1sultamicillin (ampicillin-sulbactam)FDA LinkGeneric
11/2002
1Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric
11/2002
1Ticarcillin (Tarcil)FDA Link
11/2002
1Cefoxitin (Cefoxitin Sodium)FDA LinkGeneric
11/2002
1Chloramphenicol (Chloromycetin)FDA Link
11/2002
1Ciprofloxacin (Cipro)FDA LinkGeneric
11/2002
1Clindamycin (Cleocin)FDA LinkGeneric
11/2002
1Thalidomide (Thalomid)FDA Link
05/2002

Therapy/Procedure

16Therapeutics
01/2019 - 09/2002
1Art Therapy
12/2018
1Highly Active Antiretroviral Therapy (HAART)
09/2012